Immunovant, Inc. (IMVT)
NASDAQ·Healthcare·Biotechnology
$33.79
+2.87%
Mkt Cap $6.49B
Analyst Ratings
Buy
6
Hold
4
Sell
0
Price Target (9 analysts)
$45.50
Range $41.00 – $50.00
Implied Upside
+34.7%
Consensus $45.50 vs current $33.79
NASDAQ·Healthcare·Biotechnology
$33.79
+2.87%
Mkt Cap $6.49B
Buy
6
Hold
4
Sell
0
Price Target (9 analysts)
$45.50
Range $41.00 – $50.00
+34.7%
Consensus $45.50 vs current $33.79